Guido Domenighetti
Overview
Explore the profile of Guido Domenighetti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
660
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Salomon J, Stolz D, Domenighetti G, Frey J, Turk A, Azzola A, et al.
Respir Res
. 2017 Jan;
18(1):13.
PMID: 28077140
Background: Dual bronchodilator therapy is recommended for symptomatic patients with chronic obstructive pulmonary disease (COPD). There are limited data on effects of a combination of two long-acting bronchodilators on lung...
3.
Speich R, Ulrich S, Domenighetti G, Huber L, Fischler M, Treder U, et al.
Respiration
. 2015 Jun;
89(6):515-24.
PMID: 26043786
Background: Antiproliferative strategies have emerged as a potential therapeutic option for pulmonary arterial hypertension (PAH). Objective: To evaluate the long-term efficacy and safety of imatinib. Methods: This is an observational...
4.
Mueller-Mottet S, Stricker H, Domenighetti G, Domeninghetti G, Azzola A, Geiser T, et al.
Respiration
. 2015 Feb;
89(2):127-40.
PMID: 25661477
Background: Registries are important for real-life epidemiology on different pulmonary hypertension (PH) groups. Objective: To provide long-term data of the Swiss PH registry of 1998-2012. Methods: PH patients have been...
5.
Speich R, Treder U, Domenighetti G, Huber L, Ulrich S
Int J Clin Pharm
. 2013 Nov;
36(2):256-60.
PMID: 24287663
Introduction: Despite new treatment options targeted at its three main pathogenic pathways, prognosis of idiopathic pulmonary arterial hypertension has remained dismal, with 3-year survival rates around 70 %. Antiproliferative agents...
6.
7.
Pagnamenta A, Rabito G, Arosio A, Perren A, Malacrida R, Barazzoni F, et al.
Ann Intensive Care
. 2012 Nov;
2(1):47.
PMID: 23174137
Unlabelled: Background: Adverse events (AEs) frequently occur in intensive care units (ICUs) and affect negatively patient outcomes. Targeted improvement strategies for patient safety are difficult to evaluate because of the...
8.
Salvade I, Domenighetti G, Jolliet P, Maggiorini M, Rothen H
Swiss Med Wkly
. 2012 Apr;
142:w13551.
PMID: 22481224
The real utilisation scenario of non-invasive ventilation (NIV) in Swiss ICUs has never been reported. Using a survey methodology, we developed a questionnaire sent to the directors of the 79...
9.
Nava S, Schreiber A, Domenighetti G
Respir Care
. 2011 Oct;
56(10):1583-8.
PMID: 22008399
Few studies have been performed on noninvasive ventilation (NIV) to treat hypoxic acute respiratory failure in patients with acute lung injury (ALI) or acute respiratory distress syndrome (ARDS). The outcomes...
10.
Merlani P, Verdon M, Businger A, Domenighetti G, Pargger H, Ricou B
Am J Respir Crit Care Med
. 2011 Aug;
184(10):1140-6.
PMID: 21852543
Rationale: The stressful work environment of ICUs can lead to burnout. Burnout can impact on the welfare and performance of caregivers, and may lead them to resign their job. The...